Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Balcinrenone Alone and With Itraconazole in Healthy Volunteers
NCT03843060Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2019
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of balcinrenone in heart failure with preserved ejection fraction (HFpEF) (2 arms), sponsored by AstraZeneca. Primary endpoints: Area under plasma concentration-time curve from time zero to infinity, Area under the plasma concentration-time curve from time zero to time of last quantifiable concentration and 1 more. Started Feb 2019; status: completed.
02
Drugs
balcinrenone
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT03843060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03843060.